Moneycontrol
HomeNewsBusinessFinally can see light at the end of the tunnel, says Mumbai International Airport CEO

Finally can see light at the end of the tunnel, says Mumbai International Airport CEO

In an interview with Moneycontrol, Rajeev Jain talks about the 'unprecendented' damage caused by COVID-19 on the airports business. A recovery in passenger traffic now gives hope for a gradual recovery.

January 07, 2021 / 16:41 IST
Story continues below Advertisement

After a year of unprecedented disruption, caused by COVID-19, Mumbai International Airport Ltd (MIAL) is finally seeing "some light at the end of the tunnel," its Chief Executive Officer Rajeev Jain said in an interview.

"We are optimistic as two vaccines have been cleared and the roll-out will happen soon. Also, passengers no longer have the fear of travelling," Jain told Moneycontrol.

Story continues below Advertisement

While passenger loads were just at about 20 percent when domestic flights resumed in May, said Jain, occupancy has improved. Industry observers now put average passenger loads at a range of 55 to 60 percent. Overall passenger traffic has continued to grow, increasing by 22 percent in December from a month ago.

Jain expects domestic air passenger traffic to maintain its gradual recovery and reach pre-COVID-19 levels by the end of 2021. International travel, however, may take longer and may not 'normalise' before 2023.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show